• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human CDK4 Polyclonal Antibody

The antibody against CDK4 was raised in Rabbit using a synthetic peptide corresponding to a sequence within amino acids 200-303 of human CDK4 (NP_000066.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, IF/ICC, IP, ELISA.

ADA-16679A

The antibody against CDK4 was raised in Rabbit using a synthetic peptide corresponding to a sequence within amino acids 200-303 of human CDK4 (NP_000066.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IHC-P, IF/ICC, IP, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-16679A ClonalityPolyclonal
Host SpeciesRabbitTarget NameCDK4
Target SynonymsCMM3; PSK-J3; K4FormLiquid
Species ReactivityHuman, MouseIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesHeLa, 293TApplicationELISA, WB, IF/ICC, IHC-P, IP

Immunogen Information


Immunogen DescriptionA synthetic peptide corresponding to a sequence within amino acids 200-303 of human CDK4 (NP_000066.1).Target SpeciesHuman
Immunogen SequenceVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPEUniprot IDP11802
Background Information
  • Uniprot Id

    P11802

  • Target Species

    Human

  • Target Name

    CDK4

  • Target Full Name

    Cyclin-dependent kinase 4

  • Target Function

    Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

  • Target Involvement

    Melanoma, cutaneous malignant 3 (CMM3)

  • Target Subcellular Location

    Cytoplasm. Nucleus. Nucleus membrane.

  • Target Protein Families

    Protein kinase superfamily, CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily

  • Target Research Area

    Cancer, Cell Cycle

  • Target Synonyms

    Cdk 4; cdk4; CDK4 protein; CDK4_HUMAN; Cell division kinase 4; Cell division protein kinase 4; CMM 3; CMM3; Crk3; Cyclin dependent kinase 4; Cyclin-dependent kinase 4; Melanoma cutaneous malignant 3; MGC14458; p34 cdk4; PSK J3; PSK-J3

  • Target Background

    The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported.

Inquire Rabbit anti-Human CDK4 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification